Cardiac rhythm management devices are implantable medical devices which are used for cardiac resynchronization or for providing therapeutic solutions to patients suffering from cardiac arrhythmias. Cardiac arrhythmias are a group of cardiac disorders causing irregular heartbeats. These diseases are caused as a result of an interference with the electrical activity in the atria or upper chambers of the heart. These diseases obstruct the flow of blood through the heart and cause extreme fatigue, lightheadedness, chest pain and palpitations. Irregular heartbeats can also cause blood clots and can cause strokes in cases where the clot breaks and travels to the brain. Some of the major types of cardiac arrhythmias include tachycardia, atrial fibrillation, Brugada Syndrome, familial atrial fibrillation, Wolf-Parkinson-White-Syndrome, Romano-Ward syndrome, short QT syndrome and Jervell and Lange-Nielsen syndrome.
The high global prevalence of cardiac arrhythmias is the primary growth driver of the global cardiac rhythm management devices market. Moreover, growing incidence rates of cardiac arrhythmias as a result of the growing global base of geriatric population will serve this market as a driver. According to the United Nations, the global share of population over the age of 65 years will increase from 7% in 2000 to 16% in 2050. Factors such as growing global number of cases of lifestyle habits such as smoking, excessive alcohol consumption and obesity, which makes a person more susceptible to cardiac arrhythmias and rising patient awareness levels will also drive the growth of this market.
The presence of high unmet medical needs coupled with constantly improving healthcare infrastructure in emerging Asian and Latin American regions and the introduction of technologically advanced systems such as the [email protected] transmitter wireless technology by St. Jude Medican are some of the future growth opportunities of the market.
The North American cardiac rhythm management devices market is expected to dominate the overall market throughout the forecast period. The presence of high patient awareness levels, sophisticated healthcare infrastructure and reimbursement frameworks and the high prevalence of cardiac arrhythmia disorders in the U.S. are some of the factors attributing to the aforementioned inference. The Asia-Pacific market however, will grow at the fastest pace during the forecast period owing to the presence of high future growth opportunities in terms of unmet medical needs in this region.
This research study encompasses a competitive landscape of the cardiac rhythm management devices market. Revenue analysis, product benchmarking and strategic developments of key market players such as St. Jude Medical, Medtronic Inc., Boston Scientific Corporation, Philips Healthcare, GE Healthcare and others are also provided in this report.
This report, by Grand View Research, takes a closer look at the cardiac rhythm management devices industry, providing a holistic perspective on market dynamics, trends, supply and demand. The report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including pacemakers, defibrillators, cardiac resynchronization therapy devices and others. The report also provides the same level of information for key regional markets.
This research report analyzes various factors which has been driving and inhibiting the global cardiac rhythm management devices market in the past. In addition, the report analyzes the impact of each driver and restraint on the market growth, which forms the base for market forecast. The report also showcases the opportunities available in the market which may act as future drivers for the market.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.